Joshua D Dahlke1, Hector Mendez-Figueroa2, Lindsay Maggio3, Alisse K Hauspurg3, Jeffrey D Sperling3, Suneet P Chauhan2, Dwight J Rouse3. 1. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Nebraska Methodist Women's Hospital and Perinatal Center, Omaha, NE. Electronic address: joshua.dahlke@nmhs.org. 2. Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, UT Health-University of Texas Medical School at Houston, Houston, TX. 3. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI.
Abstract
OBJECTIVE: The purpose of this study was to compare 4 national guidelines for the prevention and management of postpartum hemorrhage (PPH). STUDY DESIGN: We performed a descriptive analysis of guidelines from the American College of Obstetrician and Gynecologists practice bulletin, the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, the Royal College of Obstetrician and Gynaecologists (RCOG), and the Society of Obstetricians and Gynaecologists of Canada on PPH to determine differences, if any, with regard to definitions, risk factors, prevention, treatment, and resuscitation. RESULTS: PPH was defined differently in all 4 guidelines. Risk factors that were emphasized in the guidelines conferred a high risk of catastrophic bleeding (eg, previous cesarean delivery and placenta previa). All organizations, except the American College of Obstetrician and Gynecologists, recommended active management of the third stage of labor for primary prevention of PPH in all vaginal deliveries. Oxytocin was recommended universally as the medication of choice for PPH prevention in vaginal deliveries. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists and RCOG recommended development of a massive transfusion protocol to manage PPH resuscitation. Recommendations for nonsurgical treatment strategies such as uterine packing and balloon tamponade varied across all guidelines. All organizations recommended transfer to a tertiary care facility for suspicion of abnormal placentation. Specific indications for hysterectomy were not available in any guideline, with RCOG recommending hysterectomy "sooner rather than later" with the assistance of a second consultant. CONCLUSION: Substantial variation exists in PPH prevention and management guidelines among 4 national organizations that highlights the need for better evidence and more consistent synthesis of the available evidence with regard to a leading cause of maternal death.
OBJECTIVE: The purpose of this study was to compare 4 national guidelines for the prevention and management of postpartum hemorrhage (PPH). STUDY DESIGN: We performed a descriptive analysis of guidelines from the American College of Obstetrician and Gynecologists practice bulletin, the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, the Royal College of Obstetrician and Gynaecologists (RCOG), and the Society of Obstetricians and Gynaecologists of Canada on PPH to determine differences, if any, with regard to definitions, risk factors, prevention, treatment, and resuscitation. RESULTS: PPH was defined differently in all 4 guidelines. Risk factors that were emphasized in the guidelines conferred a high risk of catastrophic bleeding (eg, previous cesarean delivery and placenta previa). All organizations, except the American College of Obstetrician and Gynecologists, recommended active management of the third stage of labor for primary prevention of PPH in all vaginal deliveries. Oxytocin was recommended universally as the medication of choice for PPH prevention in vaginal deliveries. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists and RCOG recommended development of a massive transfusion protocol to manage PPH resuscitation. Recommendations for nonsurgical treatment strategies such as uterine packing and balloon tamponade varied across all guidelines. All organizations recommended transfer to a tertiary care facility for suspicion of abnormal placentation. Specific indications for hysterectomy were not available in any guideline, with RCOG recommending hysterectomy "sooner rather than later" with the assistance of a second consultant. CONCLUSION: Substantial variation exists in PPH prevention and management guidelines among 4 national organizations that highlights the need for better evidence and more consistent synthesis of the available evidence with regard to a leading cause of maternal death.
Authors: Alexander J Butwick; Eileen M Walsh; Michael Kuzniewicz; Sherian X Li; Gabriel J Escobar Journal: Transfusion Date: 2018-01-26 Impact factor: 3.157
Authors: Alexander J Butwick; Eileen M Walsh; Michael Kuzniewicz; Sherian X Li; Gabriel J Escobar Journal: Transfusion Date: 2016-09-13 Impact factor: 3.157
Authors: K Seligman; B Ramachandran; P Hegde; E T Riley; Y Y El-Sayed; L M Nelson; A J Butwick Journal: Int J Obstet Anesth Date: 2017-03-22 Impact factor: 2.603
Authors: Arielle Fein; Timothy Wen; Jason D Wright; Dena Goffman; Mary E D'Alton; Frank J Attenello; William J Mack; Alexander M Friedman Journal: J Matern Fetal Neonatal Med Date: 2019-04-09
Authors: Kartik K Venkatesh; Robert A Strauss; Chad A Grotegut; R Philip Heine; Nancy C Chescheir; Jeffrey S A Stringer; David M Stamilio; Katherine M Menard; J Eric Jelovsek Journal: Obstet Gynecol Date: 2020-04 Impact factor: 7.623